Rearrangement as a New Acquired Resistance Mechanism to Osimertinib That Responds to Crizotinib in Combination With Osimertinib in Lung Adenocarcinoma.
作者信息
Xu Caihua, Li Dapeng, Duan Weiming, Tao Min
机构信息
Department of Oncology, First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
出版信息
JTO Clin Res Rep. 2020 Mar 14;1(2):100034. doi: 10.1016/j.jtocrr.2020.100034. eCollection 2020 Jun.
Abstract
摘要
Zotero 插件